Donoghue Forlines LLC Makes New Investment in Humana Inc. $HUM

Donoghue Forlines LLC purchased a new stake in shares of Humana Inc. (NYSE:HUM) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 7,938 shares of the insurance provider’s stock, valued at approximately $2,065,000.

Several other institutional investors have also modified their holdings of HUM. Elevation Point Wealth Partners LLC acquired a new position in Humana during the second quarter worth about $32,000. Mather Group LLC. bought a new position in shares of Humana during the 3rd quarter valued at about $34,000. AlphaCore Capital LLC acquired a new position in shares of Humana in the 2nd quarter worth approximately $39,000. Private Wealth Management Group LLC raised its holdings in shares of Humana by 47.5% in the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 48 shares in the last quarter. Finally, SJS Investment Consulting Inc. raised its holdings in shares of Humana by 19,300.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock worth $50,000 after purchasing an additional 193 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Down 3.8%

Humana stock opened at $273.02 on Friday. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The company’s fifty day moving average price is $255.33 and its two-hundred day moving average price is $263.63. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02. The company has a market capitalization of $32.84 billion, a price-to-earnings ratio of 25.59, a PEG ratio of 2.25 and a beta of 0.45.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The business had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. Humana’s revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $4.16 earnings per share. On average, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. Humana’s dividend payout ratio is 33.18%.

Wall Street Analysts Forecast Growth

HUM has been the subject of a number of research reports. Robert W. Baird reduced their target price on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a report on Thursday, December 11th. Morgan Stanley reissued an “underperform” rating on shares of Humana in a research note on Thursday, December 18th. Wolfe Research boosted their target price on Humana from $300.00 to $325.00 and gave the stock an “outperform” rating in a research report on Thursday, January 8th. Truist Financial decreased their price target on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Finally, Barclays restated an “underperformer” rating on shares of Humana in a report on Monday, January 5th. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat, Humana currently has a consensus rating of “Hold” and an average price target of $293.37.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.